How big is AnaptysBio, Inc.?

Jun 22 2025 05:51 PM IST
share
Share Via
As of Jun 18, AnaptysBio, Inc. has a market capitalization of 699.84 million and reported net sales of 111.87 million with a net profit of -140.62 million over the latest four quarters. Shareholder's funds are 70.87 million, and total assets amount to 483.83 million.
As of Jun 18, AnaptysBio, Inc. has a market capitalization of 699.84 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 111.87 million, while the sum of net profit for the same period is -140.62 million.

As of Dec 24, the shareholder's funds are reported at 70.87 million, and the total assets amount to 483.83 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News